Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Study of ARQ 197 in Patients With Previously-Treated Malignant Mesothelioma

NCT01861301 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT01861301
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01861301 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Study of ARQ 197 in Patients With Previously-Treated Malignant Mesothelioma
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 2
Overall status
Terminated
Start date
January 31, 2013
Completion date
March 31, 2015
Enrollment
18 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

epithelioid mesothelioma, recurrent malignant mesothelioma, sarcomatoid mesothelioma, stage ii pleural mesothelioma, stage iii pleural mesothelioma, stage iv pleural mesothelioma